UnitedHealth Group stock rebounds following raised earnings outlook

UnitedHealth Group has shown signs of recovery after a period of weakness, with its stock price rebounding above the 400 USD mark. The company reported second-quarter revenue of 112 billion USD and an operating income of 8 billion USD, with adjusted earnings per share reaching 6.38 USD.

Management has raised its full-year outlook, projecting adjusted earnings per share between 19.50 and 20 USD for 2026. The company continues to focus on simplifying structures, reducing costs, and increasing transparency within UnitedHealthcare and Optum.